Artykuły w czasopismach na temat „GSTM1; GSTT1 Polymorphisms; Oral Cancer”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „GSTM1; GSTT1 Polymorphisms; Oral Cancer”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Gupta, Shalini, and Somali Sanyal. "Metabolic Gene Polymorphisms and Antioxidant Influence Risk of Pre Oral Cancer and Oral Cancer." Cancer Research and Cellular Therapeutics 7, no. 1 (2023): 01–10. http://dx.doi.org/10.31579/2640-1053/129.
Pełny tekst źródłaSreelekha, T. T., K. Ramadas, M. Pandey, G. Thomas, K. R. Nalinakumari, and M. R. Pillai. "Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer." Oral Oncology 37, no. 7 (2001): 593–98. http://dx.doi.org/10.1016/s1368-8375(01)00028-8.
Pełny tekst źródłaKrüger, Maximilian, Andreas Max Pabst, Benjamin Mahmoodi, Burkhard Becker, Peer Wolfgang Kämmerer, and Felix Peter Koch. "The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer." Clinical Oral Investigations 19, no. 8 (2015): 1791–97. http://dx.doi.org/10.1007/s00784-015-1400-0.
Pełny tekst źródłaVarela-Lema, L., A. Ruano-Ravina, M. A. Juiz Crespo, K. T. Kelsey, L. Loidi, and J. M. Barros-Dios. "CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study." Journal of Oncology 2008 (2008): 1–11. http://dx.doi.org/10.1155/2008/741310.
Pełny tekst źródłaPradhan, Devina, Tarang Mehta, Arpita Srivastava, et al. "Evaluation of the Importance of Genetic Polymorphisms in Genes Expressing Cancer-Metabolizing Enzymes (Cyp1a1 and Gstm1) in Oral Submucous Fibrosis." Journal of Pharmacy and Bioallied Sciences 16, Suppl 3 (2024): S2785—S2787. http://dx.doi.org/10.4103/jpbs.jpbs_413_24.
Pełny tekst źródłaBuch, S. C. "Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population." Carcinogenesis 23, no. 5 (2002): 803–7. http://dx.doi.org/10.1093/carcin/23.5.803.
Pełny tekst źródłaTanwar Renu, Asha R. Iyengar, and Kekkeri Sitaram Nagesh. "GSTM1 null polymorphism – a possible key for oral carcinogenesis." RSBO 10, no. 1 (2014): 76–81. http://dx.doi.org/10.21726/rsbo.v10i1.899.
Pełny tekst źródłaSharma, Tusha, Basu D. Banerjee, Gaurav K. Thakur, Kiran Guleria, and Darshana Mazumdar. "Polymorphism of xenobiotic metabolizing gene and susceptibility of epithelial ovarian cancer with reference to organochlorine pesticides exposure." Experimental Biology and Medicine 244, no. 16 (2019): 1446–53. http://dx.doi.org/10.1177/1535370219878652.
Pełny tekst źródłaAnantharaman, Devasena, Pranay M. Chaubal, Sadhana Kannan, Rajani A. Bhisey, and Manoj B. Mahimkar. "Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator." Carcinogenesis 28, no. 7 (2007): 1455–62. http://dx.doi.org/10.1093/carcin/bgm038.
Pełny tekst źródłaMadhulatha, G., Satrupa Das, N. Venkateswarlu, Akhilesh Pujar, Akka Jyothy, and Anjana Munshi. "GSTM1 and GSTT1 null polymorphism and antioxidant levels in oral submucous fibrosis, leukoplakia and oral cancer patients among a South Indian Population." Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology 30, no. 2 (2018): 169–74. http://dx.doi.org/10.1016/j.ajoms.2017.11.008.
Pełny tekst źródłaLiu, Haitao, Jinlin Jia, Xuemei Mao, and Zhiyong Lin. "Association of CYP1A1 and GSTM1 Polymorphisms With Oral Cancer Susceptibility." Medicine 94, no. 27 (2015): e895. http://dx.doi.org/10.1097/md.0000000000000895.
Pełny tekst źródłaZhao, Su-Feng, Xu-Dong Yang, Ming-Xing Lu, et al. "GSTM1 null polymorphisms and oral cancer risk: a meta-analysis." Tumor Biology 35, no. 1 (2013): 287–93. http://dx.doi.org/10.1007/s13277-013-1037-z.
Pełny tekst źródłaChatterjee, Sumana, Soujatya Dhar, Bani Sengupta, et al. "Polymorphisms of CYP1A1, GSTM1 and GSTT1 Loci as the Genetic Predispositions of Oral Cancers and Other Oral Pathologies: Tobacco and Alcohol as Risk Modifiers." Indian Journal of Clinical Biochemistry 25, no. 3 (2010): 260–72. http://dx.doi.org/10.1007/s12291-010-0057-3.
Pełny tekst źródłaCha, In-Ho, Jong Yun Park, Won-Yoon Chung, Min-Ah Choi, Hyung-Jun Kim, and Kwang-Kyun Park. "Polymorphisms of CYP1A1 and GSTM1 Genes and Susceptibility to Oral Cancer." Yonsei Medical Journal 48, no. 2 (2007): 233. http://dx.doi.org/10.3349/ymj.2007.48.2.233.
Pełny tekst źródłaAbraham, M. T., L. P. Karen-Ng, W. M. N. Ghani, R. B. Zain, R. J. Raja-Latifah, and S. C. Cheong. "P3.56. CYP1A1, GSTM1 and GSTT1 polymorphisms and oral cancer – Correlation with patients’ status at 2-year, age of onset, nodal status, tumor size and stage." Oral Oncology Supplement 3, no. 1 (2009): 219–20. http://dx.doi.org/10.1016/j.oos.2009.06.582.
Pełny tekst źródłaZhang, Z. J., K. Hao, R. Shi, et al. "Glutathione S-Transferase M1 (GSTM1) and Glutathione S-Transferase T1 (GSTT1) Null Polymorphisms, Smoking, and Their Interaction in Oral Cancer: A HuGE Review and Meta-Analysis." American Journal of Epidemiology 173, no. 8 (2011): 847–57. http://dx.doi.org/10.1093/aje/kwq480.
Pełny tekst źródłaShukla, Deepika, Alka Dinesh Kale, Seema Hallikerimath, Venkatakanthaiah Yerramalla, Vivekanandhan Subbiah, and Shashwat Mishra. "Association between GSTM1 and CYP1A1 polymorphisms and survival in oral cancer patients." Biomedical Papers 157, no. 4 (2013): 304–10. http://dx.doi.org/10.5507/bp.2013.028.
Pełny tekst źródłaCARRICA, VICTIRUANO ANDRES, IRAZUZTA GRACIANA, UNAMUNO VICTORIA, et al. "CARCINOGEN-RELATED CYP1A1 AND GSTM1 GENETIC POLYMORPHISMS IN ORAL CANCER AND ORAL POTENTIALLY MALIGNANT DISORDERS." Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 129, no. 1 (2020): e154. http://dx.doi.org/10.1016/j.oooo.2019.06.661.
Pełny tekst źródłaZhuo, Wenlei, Yan Wang, Xianlu Zhuo, et al. "CYP1A1 and GSTM1 Polymorphisms and Oral Cancer Risk: Association Studies Via Evidence-Based Meta-Analyses." Cancer Investigation 27, no. 1 (2009): 86–95. http://dx.doi.org/10.1080/07357900802146170.
Pełny tekst źródłaMahimkar, Manoj B., Tanuja A. Samant, Sadhana Kannan, Jatin Tulsulkar, Prathamesh S. Pai, and Devasena Anantharaman. "Polymorphisms in GSTM1 and XPD genes predict clinical outcome in advanced oral cancer patients treated with postoperative radiotherapy." Molecular Carcinogenesis 51, S1 (2011): E94—E103. http://dx.doi.org/10.1002/mc.21868.
Pełny tekst źródłaYadav, Binod Kumar, Jatinder Kaur, Anurag Srivastava, and Ranju Ralhan. "Effect of polymorphisms in XRCC1, CCND1 and GSTM1 and tobacco exposure as risk modifier for oral leukoplakia." International Journal of Biological Markers 24, no. 2 (2009): 90–98. http://dx.doi.org/10.5301/jbm.2009.5376.
Pełny tekst źródłaKaren-Ng, L. P., W. M. N. Ghani, A. Vimmitra, et al. "O46. Aldehyde dehydrogenase 2 (ALDH2) and glutathione S-transferase M1 (GSTM1) polymorphisms in relation to oral cancer risk among Malaysians." Oral Oncology 47 (July 2011): S43—S44. http://dx.doi.org/10.1016/j.oraloncology.2011.06.157.
Pełny tekst źródłaOlivieri, Eloisa Helena Ribeiro, Sabrina Daniela da Silva, Fernando Fernandes Mendonça, et al. "CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients." Oral Oncology 45, no. 9 (2009): e73-e79. http://dx.doi.org/10.1016/j.oraloncology.2009.03.004.
Pełny tekst źródłaPatel, Shiv Kumar, and Mitashree Mitra. "Inter-Gene and Gene - Environment Interactions Associated with CYP1A1 and GSTM1 Gene Polymorphisms and Risk of Oral Cancer in Chhattisgarh Population, India." Asian Man (The) - An International Journal 6, no. 2 (2012): 135. http://dx.doi.org/10.5958/j.0975-6884.6.2.005.
Pełny tekst źródłaChatterjee, A., A. Banerjee, P. Yadav, et al. "AA Homozygous Genotype of GSTP1 I105V Polymorphism in Oral Cancer: In Silico Screening, Molecular Dynamics Simulation and Activity Studies of Wild and Mutant GSTP1." Journal of Global Oncology 4, Supplement 2 (2018): 42s. http://dx.doi.org/10.1200/jgo.18.33900.
Pełny tekst źródłaChen, Han-chun, Yan-fei Cao, Wei-xin Hu, et al. "Genetic Polymorphisms of Phase II Metabolic Enzymes and Lung Cancer Susceptibility in a Population of Central South China." Disease Markers 22, no. 3 (2006): 141–52. http://dx.doi.org/10.1155/2006/436497.
Pełny tekst źródłaDuarte, Eliza Carla Barroso, Marina Sena Lopes Silva, Marcus Vinicius Gomez, and Ricardo Santiago Gomez. "GSTM1 polymorphism and oral leukoplakia." Journal of Oral Pathology and Medicine 35, no. 4 (2006): 202–5. http://dx.doi.org/10.1111/j.1600-0714.2006.00405.x.
Pełny tekst źródłaAguiar, Ernestina Silva de, Juliana Giacomazzi, Aishameriane Venes Schmidt, et al. "GSTM1, GSTT1, and GSTP1 polymorphisms, breast cancer risk factors and mammographic density in women submitted to breast cancer screening." Revista Brasileira de Epidemiologia 15, no. 2 (2012): 246–55. http://dx.doi.org/10.1590/s1415-790x2012000200002.
Pełny tekst źródłaLiu, Chunmei, Yan Zeng, Xizhen Ma, et al. "An Updated Meta-Analysis: Cervical Cancer Risk Conferred by GSTM1 and GSTT1 Polymorphisms." International Journal of Sciences Volume 6, no. 2017-01 (2017): 52–63. https://doi.org/10.5281/zenodo.3349335.
Pełny tekst źródłaDrummond, Sérgio Neves, Luiz De Marco, Júlio Carlos Motta Noronha, and Ricardo Santiago Gomez. "GSTM1 polymorphism and oral squamous cell carcinoma." Oral Oncology 40, no. 1 (2004): 52–55. http://dx.doi.org/10.1016/s1368-8375(03)00132-5.
Pełny tekst źródłaHireche, Ahmed, Naouel Chaoui Kherouatou, Asma Ribouh, Noureldine Abadi, Ming Jun Shi, and Dalila Satta. "POLYMORPHIC DELETIONS OF GLUTATHIONE S-TRANSFERASES M1, T1 AND BLADDER CANCER RISK IN ALGERIAN POPULATION." Asian Journal of Pharmaceutical and Clinical Research 11, no. 5 (2018): 458. http://dx.doi.org/10.22159/ajpcr.2018.v11i5.25673.
Pełny tekst źródłaAlmeida, Micaela, Mafalda Soares, José Fonseca-Moutinho, Ana Cristina Ramalhinho, and Luiza Breitenfeld. "Influence of Estrogenic Metabolic Pathway Genes Polymorphisms on Postmenopausal Breast Cancer Risk." Pharmaceuticals 14, no. 2 (2021): 94. http://dx.doi.org/10.3390/ph14020094.
Pełny tekst źródłaSánchez-Siles, Mariano, Juan Pablo Pelegrín-Hernández, Diego Hellin-Meseguer, et al. "Genotype of Null Polymorphisms in Genes GSTM1, GSTT1, CYP1A1, and CYP1A1*2A (rs4646903 T>C)/CYP1A1*2C (rs1048943 A>G) in Patients with Larynx Cancer in Southeast Spain." Cancers 12, no. 9 (2020): 2478. http://dx.doi.org/10.3390/cancers12092478.
Pełny tekst źródłaAlexandrie, Anna-Karin, Fredrik Nyberg, Margareta Warholm, and Agneta Rannug. "Influence of CYP1A1, GSTM1, GSTT1, and NQO1 Genotypes and Cumulative Smoking Dose on Lung Cancer Risk in a Swedish Population." Cancer Epidemiology, Biomarkers & Prevention 13, no. 6 (2004): 908–14. http://dx.doi.org/10.1158/1055-9965.908.13.6.
Pełny tekst źródłaAguiar, E., J. Giacomazzi, E. I. Palmero, et al. "Null allele polymorphisms in the GSTT1 and GSTM1 genes in 705 women from a mammographic breast cancer screening program (NMPOA) in southern Brazil." Journal of Clinical Oncology 25, no. 18_suppl (2007): 21091. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.21091.
Pełny tekst źródłaMoawia, S., M. Elbordiny, and A. Saad. "Glutathione S-transferase T1, M1 genetic polymorphisms in cases of acute leukemia." Journal of Clinical Oncology 25, no. 18_suppl (2007): 7053. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.7053.
Pełny tekst źródłaSaad, A. A., P. J. O'Connor, M. H. Mostafa, et al. "Glutathione S-Transferase M1, T1 and P1 Polymorphisms and Bladder Cancer Risk in Egyptians." International Journal of Biological Markers 20, no. 1 (2005): 69–72. http://dx.doi.org/10.1177/172460080502000111.
Pełny tekst źródłaCosta, Ana Carolina Messias de Souza Ferreira da, Marcela Brennand Pina Moreira, Amina Kadja Martins Cahú, et al. "Null polymorphism of the GSTM1 and GSTT1 genes in susceptibility to colorectal tumorigenesis: systematic review with meta-analysis." Caderno Pedagógico 21, no. 9 (2024): e7360. http://dx.doi.org/10.54033/cadpedv21n9-008.
Pełny tekst źródłaSkulskaya, S. V., T. G. Verbickaya та S. A. Shnajder. "PROBABILITY OF DENTAL PATHOLOGY DEVELOPMENT IN CHILDREN RESIDING IN ZONES OF VARIOUS ANTHROPOGENIC LOADS BASED ON MOLECULAR GENETIC EVALUATION OF POLYMORPHISMS OF І AND ІІ PHASE OF DETOXICATION". EurasianUnionScientists 3, № 3(72) (2020): 37–41. http://dx.doi.org/10.31618/esu.2413-9335.2020.3.72.637.
Pełny tekst źródłaHa, Yun-Sok, Chunri Yan, Min Su Lym, et al. "GSTT1as a Prognosticator for Recurrence and Progression in Patients with Non-Muscle-Invasive Bladder Cancer." Disease Markers 29, no. 2 (2010): 81–87. http://dx.doi.org/10.1155/2010/816149.
Pełny tekst źródłaKim, Sung-Doo, Je-Hwan Lee, Seong-Gil Ryu, et al. "Influence of Glutathione S-Transferase (GST) Gene Polymorphisms On the Clearance of Intravenous Busulfan in Adult Patients Undergoing Hematopoietic Cell Transplantation." Blood 114, no. 22 (2009): 1179. http://dx.doi.org/10.1182/blood.v114.22.1179.1179.
Pełny tekst źródłaEconomopoulos, Konstantinos P., Theodoros N. Sergentanis, and Nikos F. Vlahos. "Glutathione S-transferase M1, T1, and P1 Polymorphisms and Ovarian Cancer Risk: A Meta-Analysis." International Journal of Gynecologic Cancer 20, no. 5 (2010): 732–37. http://dx.doi.org/10.1111/igc.0b013e3181dedeb5.
Pełny tekst źródłaDavies, Stella M., Leslie L. Robison, Jonathan D. Buckley, et al. "Glutathione S-Transferase Polymorphisms and Outcome of Chemotherapy in Childhood Acute Myeloid Leukemia." Journal of Clinical Oncology 19, no. 5 (2001): 1279–87. http://dx.doi.org/10.1200/jco.2001.19.5.1279.
Pełny tekst źródłaTrujillo-Paolillo, Alini, Carolina Salinas-Souza, Indhira Dias-Oliveira, Antonio Sergio Petrilli, and Silvia R. C. Toledo. "Role of glutathione S-transferase and cytochrome P-450 polymorphisms in the clinical outcome of osteosarcoma patients." Journal of Clinical Oncology 31, no. 15_suppl (2013): 10535. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.10535.
Pełny tekst źródłaIsakova, Zh, Vyacheslav Kipen, K. Aytbaev, et al. "POLYMORPHISMS IN GSTM1, GSTP1 AND GSTT1 GENES AND BREAST CANCER RISK IN WOMEN FROM KYRGYZSTAN." Problems in oncology 66, no. 5 (2020): 514–23. http://dx.doi.org/10.37469/0507-3758-2020-66-5-514-523.
Pełny tekst źródłaMilosevic-Djordjevic, Olivera, Darko Grujicic, Marina Radovic-Jakovljevic, et al. "Influence of GSTT1 and GSTM1 null genotypes on differentiated thyroid cancer risk and baseline and radioiodine induced cytogenetic damage in peripheral blood lymphocytes of patients." Genetika 49, no. 2 (2017): 599–611. http://dx.doi.org/10.2298/gensr1702599m.
Pełny tekst źródłaDiakite, Brehima, Yaya Kassogue, Mamoudou Maïga, et al. "Abstract 6833: Influence of guthation S transferase T1 and M1 polymorphisms on tamoxifen metabolism in malian women with breast cancer." Cancer Research 85, no. 8_Supplement_1 (2025): 6833. https://doi.org/10.1158/1538-7445.am2025-6833.
Pełny tekst źródłaGronau, S., D. Koenig-Greger, M. Jerg, and H. Riechelmann. "Gene Polymorphisms in Detoxification Enzymes as Susceptibility Factor for Head and Neck Cancer?" Otolaryngology–Head and Neck Surgery 128, no. 5 (2003): 674–80. http://dx.doi.org/10.1016/s0194-59980300176-1.
Pełny tekst źródłaDeMichele, Angela, Richard Aplenc, Jeffrey Botbyl, et al. "Drug-Metabolizing Enzyme Polymorphisms Predict Clinical Outcome in a Node-Positive Breast Cancer Cohort." Journal of Clinical Oncology 23, no. 24 (2005): 5552–59. http://dx.doi.org/10.1200/jco.2005.06.208.
Pełny tekst źródłaSahoo, Pranab Kumar, Tanuma Mistry, SUSHMITA GHOSH, et al. "Clinical implications of drug-metabolizing genes CYP3A4 and GSTP1 single nucleotide polymorphisms in oral cancer patients undergoing induction chemotherapy." JCO Global Oncology 9, Supplement_1 (2023): 95. http://dx.doi.org/10.1200/go.2023.9.supplement_1.95.
Pełny tekst źródła